Skip to main content
Log in

SARC-F as a Screening Tool for Sarcopenia and Possible Sarcopenia Proposed by AWGS 2019 in Hospitalized Older Adults

  • Published:
The journal of nutrition, health & aging

Abstract

Object

The SARC-F questionnaire is a sarcopenia screening tool. However, the validity of the SARC-F score ≥4 (SARC-F≥4) for the evaluation of sarcopenia in the hospital setting has not been investigated. This study investigated the validity of SARC-F≥4 as a screening tool for sarcopenia among hospitalized older adults.

Design

Cross-sectional retrospective study.

Setting

A university hospital.

Participants

This study included older adult patients (age ≥65 years) who were hospitalized at, and subsequently discharged from, the hospital between April and September 2019 and underwent a nutritional assessment by the nutrition support team during their hospitalization.

Measurements

SARC-F was recorded at the time of admission, and the criteria specified by the Asia Working Group for Sarcopenia in 2019 (AWGS 2019) were applied to diagnose sarcopenia and possible sarcopenia. Appendicular muscle mass was estimated through validated equations, and three different models were developed for sarcopenia diagnosis. The sensitivity, specificity, and positive/negative likelihood ratios were calculated to analyze the accuracy of the SARC-F≥4 for sarcopenia and possible sarcopenia. Receiver-operating characteristic analyses were conducted to calculate the area under the curve (AUC).

Results

In total, 1,689 patients (mean age: 77.2±13 years; male: 54.4%) were analyzed, and 636 patients (37.7%) had SARC-F≥4. Patients with SARC-F≥4 had a statistically significant higher prevalence of AWGS 2019-defined sarcopenia than patients with SARC-F <4 in the models (65.4–78.9% vs 40.9–15.2%, p<0.001). The sensitivity, specificity, and positive/negative likelihood ratios of SARC-F≥4 for sarcopenia and possible sarcopenia were 49.1–51.3%, 73.9–81.2%, and 1.88–2.72/0.60–0.69 and 48.0%, 84.5%, and 3.11/0.62, respectively. The AUC for sarcopenia and possible sarcopenia were 0.644–0.695 and 0.708, respectively. The AUC of SARC-F for possible sarcopenia was equivalent to or larger than that for sarcopenia (DeLong test p=0.438, 0.088, and <0.001 vs the three models).

Conclusions

SARC-F≥4 is suitable as a screening tool for sarcopenia in hospitalized older adults. SARC-F assessment could facilitate the detection and exclusion of sarcopenia at hospitalization and may lead to early adoption of a therapeutic and preventive approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

    Article  PubMed  Google Scholar 

  2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Maeda K, Akagi J. Sarcopenia is an independent risk factor of dysphagia in hospitalized older people. Geriatr Gerontol Int. 2016;16(4):515–21.

    Article  PubMed  Google Scholar 

  4. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.

    Article  PubMed  Google Scholar 

  5. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sei Med Sei. 2014;69(5):547–S8.

    Article  Google Scholar 

  6. Morley JE. Frailty and sarcopenia in elderly. Wien Klin Wochenschr. 2016;128(Suppl 7):439–45.

    Article  PubMed  Google Scholar 

  7. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–7e2.

    Article  PubMed  Google Scholar 

  8. Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis. J Nutr Health Aging. 2020;24(1):83–90.

    Article  CAS  PubMed  Google Scholar 

  9. Ishida Y, Maeda K, Nonogaki T, et al. Impact of edema on length of calf circumference in older adults. Geriatr Gerontol Int. 2019; 19(10):993–8.

    Article  PubMed  Google Scholar 

  10. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):S31–2.

    Article  Google Scholar 

  11. Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2018;19(1):40–Se1.

    Article  PubMed  Google Scholar 

  12. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36.

    Article  PubMed  Google Scholar 

  13. Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc. 2014; 15(9):630–4.

    Article  PubMed  Google Scholar 

  14. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015; 16(3):247–52.

    Article  PubMed  Google Scholar 

  15. Ida S, Murata K, Nakadachi D, et al. Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res. 2017;29(S):935–42.

    Article  PubMed  Google Scholar 

  16. Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc. 2016; 17(12): 1142–6.

    Article  PubMed  Google Scholar 

  17. Rolland Y, Dupuy C, Abellan Van Kan G, et al. Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study. J Am Med Dir Assoc. 2017; 18(10):848–52.

    Article  PubMed  Google Scholar 

  18. Kotlarczyk MP, Perera S, Nace DA, Resnick NM, Greenspan SL. Identifying Sarcopenia in Female Long-Term Care Residents: A Comparison of Current Guidelines. J Am Geriatr Soc. 2018;66(2):316–20.

    Article  PubMed  Google Scholar 

  19. Locquet M, Beaudart C, Reginster JY, Petermans J, Bruyère O. Comparison of the performance of five screening methods for sarcopenia. Clin Epidemiol. 2018; 10:71–82.

    Article  PubMed  Google Scholar 

  20. Bahat G, Yilmaz O, Kilic C, Oren MM, Karan MA. Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. J Nutr Health Aging. 2018;22(8):898–903.

    Article  CAS  PubMed  Google Scholar 

  21. Mienche M, Setiati S, Setyohadi B, et al. Diagnostic Performance of Calf Circumference, Thigh Circumference, and SARC-F Questionnaire to Identify Sarcopenia in Elderly Compared to Asian Working Group for Sarcopenia’s Diagnostic Standard. Acta Medlndones. 2019;51(2): 117–27.

    Google Scholar 

  22. Kera T, Kawai H, Hirano H, et al. SARC-F: A validation study with community-dwelling older Japanese adults. Geriatr Gerontol Int. 2019;19(11):1172–8.

    Article  PubMed  Google Scholar 

  23. Kurita N, Wakita T, Kamitani T, Wada O, Mizuno K. SARC-F Validation and SARC-F+EBM Derivation in Musculoskeletal Disease: The SPSS-OK Study. J Nutr Health Aging. 2019;23(8):732–8.

    Article  CAS  PubMed  Google Scholar 

  24. Drey M, Ferrari U, Schraml M, et al. German Version of SARC-F: Translation, Adaption, and Validation. J Am Med Dir Assoc. 2020.

  25. Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNASF). J Gerontol A Biol Sei Med Sei. 2001;56(6):M366–72.

    Article  CAS  Google Scholar 

  26. Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition — An ESPEN Consensus Statement. Clin Nutr. 2015;34(3):335–40.

    Article  CAS  PubMed  Google Scholar 

  27. Ishida Y, Maeda K, Nonogaki T, et al. Malnutrition at Admission Predicts In-Hospital Falls in Hospitalized Older Adults. Nutrients. 2020; 12(2).

    Google Scholar 

  28. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  CAS  PubMed  Google Scholar 

  29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  CAS  PubMed  Google Scholar 

  30. Santos LP, Gonzalez MC, Orlandi SP, et al. New Prediction Equations to Estimate Appendicular Skeletal Muscle Mass Using Calf Circumference: Results From NHANES 1999–2006. JPEN J Parenter Enteral Nutr. 2019;43(8):998–1007.

    Article  PubMed  Google Scholar 

  31. Wen X, Wang M, Jiang CM, Zhang YM. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20(4):551–6.

    PubMed  Google Scholar 

  32. Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. HI. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703–7.

    Article  CAS  PubMed  Google Scholar 

  33. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17(8):646–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by the Japan Society for the Promotion of Science (grant number: JP20H01144to Ishida Y and 18K11142 to Maeda K)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keisuke Maeda.

Ethics declarations

Ethical standards: This work was performed according to the ethical standards laid down in the 1964 Declaration of Helsinki and later amendments.

Conflict of Interest: The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ishida, Y., Maeda, K., Nonogaki, T. et al. SARC-F as a Screening Tool for Sarcopenia and Possible Sarcopenia Proposed by AWGS 2019 in Hospitalized Older Adults. J Nutr Health Aging 24, 1053–1060 (2020). https://doi.org/10.1007/s12603-020-1462-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-020-1462-9

Key words

Navigation